Theseus Pharmaceuticals Inc (THRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | 09-2020 | 12-2019 | |
| Operating Expenses | 4,489 | 0 | 1,429 | 0 |
| Operating Income | -4,489 | N/A | -1,429 | N/A |
| Other Income | 16 | 0 | 0 | 0 |
| Pre-tax Income | -4,473 | 0 | -1,429 | 0 |
| Net Income Continuous | -4,473 | N/A | -1,429 | N/A |
| Net Income | $-4,473 | $N/A | $-1,429 | $N/A |
| EPS Basic Total Ops | -4.90 | N/A | -2.12 | N/A |
| EPS Basic Continuous Ops | -4.90 | N/A | -2.12 | N/A |
| EPS Diluted Total Ops | -4.90 | N/A | -2.12 | N/A |
| EPS Diluted Continuous Ops | -4.90 | N/A | -2.12 | N/A |
| EBITDA(a) | $-4,488 | $N/A | $-1,429 | $N/A |